Physician profile
Thomas D Koehler
NPI 1720405145
$4,087.29
in general payments reported to CMS, 2019-2025
10 companies · $2,988 in 2025
The $2,988 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $67.67 · 2024: $1,032 · 2025: $2,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,678 · Food and Beverage: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,678.36 |
| Food and Beverage | $1,341.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,086.66 | 2025 | Affinity, Puraply Wound Matrix, Novachor |
| Silk Road Medical, INC. | $993.63 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medtronic, INC. | $869.12 | 2025 | Venaseal |
| Otsuka America Pharmaceutical, INC. | $28.31 | 2022 | |
| Amgen INC. | $21.88 | 2024 | Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $20.70 | 2022 | |
| Lilly USA, LLC | $18.66 | 2022 | |
| Becton, Dickinson and Company | $16.70 | 2025 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $16.33 | 2024 | |
| Globus Medical, INC. | $15.30 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Koehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.